COSCIENS Biopharma Inc. financial data

Symbol
CSCI on Nasdaq
Industry
Pharmaceutical Preparations
Location
C/O Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53, Toronto, Ontario, Canada
State of incorporation
Ontario, Canada
Fiscal year end
December 31
Former names
Aeterna Zentaris Inc. (to 8/7/2024), AETERNA LABORATORIES INC (to 5/25/2004)
Latest financial report
20-F - Q4 2024 - Apr 9, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.14M shares -35.3%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 8.3M USD +307%
General And Administrative Expense 6.71M USD +104%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 35.1M USD +47.7%
Liabilities 21.9M USD +708%